About Us

Micrel Medical Devices SA is a medical technology company designing, manufacturing and marketing "smart" drug delivery systems. We offer a full range of ambulatory volumetric and syringe infusion pumps, administration sets, accessories as well as remote patient infusion control and monitoring systems and services for a broad array of hospital and home-based patient treatments.

Micrel is currently present, directly or through distributors, in more than 30 countries around the world.





Micrel's strengths come from the long experience in the infusion devices industry we have gained through a large established product portfolio all over the world and a combination of innovative market-driven R&D culture with flexible manufacturing. At Micrel, innovation is a way of life, at all levels of the organization. It is a continuous process that results to breakthrough product and service improvements targeted to assist patients, healthcare service providers and distributors. We develop new technologies and have a strong Intellectual Property (IP) portfolio in infusion systems supporting our product range. The company currently holds more than 20 patents on infusion technologies.


High Quality Standards

Micrel operates under the highest quality standards and is certified as follows:
ISO 9001:2008, certified by SGS UK
ISO 13485:2003 (CMDCAS), certified by SGS UK

Product Approvals & Certifications:
CE Mark Certification
US FDA 510K for MP 101 syringe driver
Local registrations in all markets Micrel is operating in


Micrel History

1980-1994

  • Founded in 1980
  • New therapies addressed during this period: Thalassemia, Blood Testing, Other therapies not related to Infusion
  • New products: MP™ Syringe Drivers, Laboratory Equipment
  • First development of  an international distribution network



1995-2000

  • Partnership with US firm Alaris Medical Systems for global distribution of a dedicated product line
  • New therapies addressed during this period: Pain Management
  • New products: Rythmic™ Peristaltic Pumps, new MP™ versions


2001-2006

  • Wide development of  an international distribution network
  • New therapies addressed during this period: Immunotherapy, Chemotherapy, Antibiotics
  • New products: New Rythmic™ and MP™ versions


2007- to date

  • Significant Therapy Diversification
  • New therapies addressed during this period: Home Parenteral Nutrition (HPN) , Primary Pulmonary Hypertension (PPH), Parkinson, Regional Anaelgesia
  • Development of Micrelcare infusion control and monitoring system
  • New products: Rythmic™ PN, Organizer 500/100 Series, Evolution, new Rythmic™ and MP™ versions, MicrelCare